Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression

被引:298
作者
Kim, I
Moon, SO
Park, SK
Chae, SW
Koh, GY
机构
[1] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Endothelial Cells, Sch Med, Chonju, South Korea
[2] Chonnam Natl Univ, Dept Internal Med, Sch Med, Chonju, South Korea
[3] Chonnam Natl Univ, Dept Pharmacol, Sch Med, Chonju, South Korea
关键词
vascular endothelial growth factor; angiopoietin; adhesion; inflammation;
D O I
10.1161/hh1801.097034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1) are potent vasculogenic and angiogenic factors that hold promise as a means to produce therapeutic vascularization and angiogenesis. However, VEGF also acts as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes; to endothelial cells, an initial and essential step toward inflammation. In the present study, we used human umbilical vascular endothelial cells (HUVECs) to examine the effect of Ang1 on VEGF-induced expression of three adhesion molecules: intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin. Interestingly, Ana1 suppressed VEGF-induced expression of these adhesion molecules. Furthermore, Angl reduced VEGF-induced leukocyte adhesion to HUVECs. These results demonstrate that Ang1 counteracts VEGF-induced inflammation by reducing VEGF-induced endothetial adhesiveness.
引用
收藏
页码:477 / 479
页数:3
相关论文
共 8 条
  • [1] Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization
    Chae, JK
    Kim, I
    Lim, ST
    Chung, MJ
    Kim, WH
    Kim, HG
    Ko, JK
    Koh, GY
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) : 2573 - 2578
  • [2] Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
    Detmar, M
    Brown, LF
    Schön, MP
    Elicker, BM
    Velasco, P
    Richard, L
    Fukumura, D
    Monsky, W
    Claffey, KP
    Jain, RK
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) : 1 - 6
  • [3] Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions
    Gamble, JR
    Drew, J
    Trezise, L
    Underwood, A
    Parsons, M
    Kasminkas, L
    Rudge, J
    Yancopoulos, G
    Vadas, MA
    [J]. CIRCULATION RESEARCH, 2000, 87 (07) : 603 - 607
  • [4] Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
    Kim, I
    Kim, HG
    So, JN
    Kim, JH
    Kwak, HJ
    Koh, GY
    [J]. CIRCULATION RESEARCH, 2000, 86 (01) : 24 - 29
  • [5] Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells
    Kim, I
    Moon, SO
    Kim, SH
    Kim, HJ
    Koh, YS
    Koh, GY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7614 - 7620
  • [6] Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
    Papapetropoulos, A
    Fulton, D
    Mahboubi, K
    Kalb, RG
    O'Connor, DS
    Li, FZ
    Altieri, DC
    Sessa, WC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9102 - 9105
  • [7] Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
    Thurston, G
    Suri, C
    Smith, K
    McClain, J
    Sato, TN
    Yancopoulos, GD
    McDonald, DM
    [J]. SCIENCE, 1999, 286 (5449) : 2511 - 2514
  • [8] Vascular-specific growth factors and blood vessel formation
    Yancopoulos, GD
    Davis, S
    Gale, NW
    Rudge, JS
    Wiegand, SJ
    Holash, J
    [J]. NATURE, 2000, 407 (6801) : 242 - 248